Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Should Pancreaticoduodenectomy Be Performed in Octogenarians?
Taylor A. Sohn
, Charles J. Yeo
, John L. Cameron
, Keith D. Lillemoe
, Mark A. Talamini
, Ralph H. Hruban
, Patricia K. Sauter
, Jo Ann Coleman
, Sarah E. Ord
, Louise B. Grochow
, Ross A. Abrams
, Henry A. Pitt
Research output
:
Contribution to journal
›
Article
›
peer-review
189
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Should Pancreaticoduodenectomy Be Performed in Octogenarians?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pancreaticoduodenectomy
100%
Octogenarians
100%
Ampullary Adenocarcinoma
22%
Chronic Pancreatitis
11%
United States
11%
Mortality Rate
11%
Morbidity Mortality
11%
5-year Survival
11%
Elderly Patients
11%
Long-term Survival
11%
Pancreatic Adenocarcinoma
11%
Pancreatic Resection
11%
Morbidity Rate
11%
Single Institution
11%
Older Patients
11%
Complication Rate
11%
Median Survival
11%
Postoperative Length of Stay
11%
Postoperative Mortality
11%
Young Subgroup
11%
Patient Selection
11%
Intraoperative Blood Loss
11%
Young Patients
11%
Blood Type
11%
Operative Time
11%
Cystadenoma
11%
Cystadenocarcinoma
11%
Bile Duct Adenocarcinoma
11%
Age Data
11%
Distal Bile Duct
11%
Duodenal Adenocarcinoma
11%
Nursing and Health Professions
Pancreaticoduodenectomy
100%
Adenocarcinoma
44%
Mortality Rate
22%
Pancreas Adenocarcinoma
11%
Long Term Survival
11%
Length of Stay
11%
Survival Rate
11%
Bleeding
11%
Elderly Patient
11%
Contraindication
11%
Perioperative
11%
Cystadenocarcinoma
11%
Cystadenoma
11%
Chronic Pancreatitis
11%
Medicine and Dentistry
Pancreaticoduodenectomy
100%
Adenocarcinoma
44%
Mortality Rate
22%
Survival Rate
11%
Bleeding
11%
Pancreas Adenocarcinoma
11%
Long Term Survival
11%
Chronic Pancreatitis
11%
Contraindication
11%
Bile Duct
11%
Elderly Patient
11%
Cystadenoma
11%
Mucinous Cystadenocarcinoma
11%